Summit Therapeutics Inc. Annual Interest Expense in USD from 2017 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Summit Therapeutics Inc. quarterly/annual Interest Expense history and growth rate from 2017 to 2022.
  • Summit Therapeutics Inc. Interest Expense for the quarter ending March 31, 2023 was $8.33M, a 5378% increase year-over-year.
  • Summit Therapeutics Inc. Interest Expense for the twelve months ending March 31, 2023 was $12.6M.
  • Summit Therapeutics Inc. annual Interest Expense for 2022 was $4.4M, a 1719% increase from 2021.
  • Summit Therapeutics Inc. annual Interest Expense for 2021 was $242K, a 5.1% decline from 2020.
  • Summit Therapeutics Inc. annual Interest Expense for 2020 was $255K, a 12.4% decline from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $4.4M +$4.16M +1719% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-09
2021 $242K -$13K -5.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $255K -$36K -12.4% Jan 1, 2020 Dec 31, 2020 10-K/A 2022-12-21
2019 $291K -$329K -53.1% Feb 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $620K -$924K -59.8% Feb 1, 2018 Jan 31, 2019 10-K 2021-03-31
2017 $1.54M Feb 1, 2017 Jan 31, 2018 8-K 2020-09-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.